WHO recommends Roche and Sanofi treatments to cut COVID-19 death risk

The WHO has recommended using arthritis drugs Actemra from Roche and Kevzara from Sanofi with corticosteroids for COVID-19 patients.

This recommendation comes after data from 11,000 patients showed that the drugs cut the risk of death.

As reported in Reuters, a WHO group evaluating therapies concluded treating severe and critical COVID patients with these treatments, interleukin-6 antagonists, that block inflammation "reduces the risk of death and the need for mechanical ventilation".

read more